Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
The drug, orforlipron, is taken daily in the morning and can be taken within 30 minutes of eating
Ma L, Lin XM
Individuals who may be at greater risk include: Those with a pre-existing diagnosis of osteoarthritis, rheumatoid arthritis, or other inflammatory joint conditions Patients with obesity-related joint loading, particularly affecting the knees, hips, and lower back Older adults, in whom musculoskeletal complaints are more prevalent at baseline Individuals experiencing rapid weight loss, which may transiently alter joint mechanics and gait, particularly in the lower limbs this is a theoretical consideration based on general musculoskeletal principles rather than retatrutide-specific evidence Significant weight reduction one of retatrutide's primary therapeutic effects is generally associated with reduced mechanical load on weight-bearing joints , which may improve joint symptoms over time in individuals with obesity-related arthropathy
Pharmacodynamically, tirzepatide is an imbalanced co-agonist, favoring GIPR over GLP-1R, with a comparable affinity for GIPR as endogenous GIP and marginally lesser affinity for GLP-1R than endogenous GLP-1
&srotate=0)
